$51.50
3.71% yesterday
Nasdaq, Apr 11, 10:15 pm CET
ISIN
US80105N1054
Symbol
SNY
Sector
Industry

Sanofi Sponsored ADR Target price 2025 - Analyst rating & recommendation

Sanofi Sponsored ADR Classifications & Recommendation:

Buy
80%
Hold
16%
Sell
4%

Sanofi Sponsored ADR Price Target

Target Price $64.49
Price $51.50
Potential
Number of Estimates 21
21 Analysts have issued a price target Sanofi Sponsored ADR 2026 . The average Sanofi Sponsored ADR target price is $64.49. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 25 analysts: 20 Analysts recommend Sanofi Sponsored ADR to buy, 4 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Sanofi Sponsored ADR stock has an average upside potential 2026 of . Most analysts recommend the Sanofi Sponsored ADR stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Billion $ 44.44 50.39
8.69% 13.39%
EBITDA Margin 31.98% 30.84%
1.42% 3.55%
Net Margin 13.54% 18.34%
5.23% 35.44%

19 Analysts have issued a sales forecast Sanofi Sponsored ADR 2025 . The average Sanofi Sponsored ADR sales estimate is

$50.4b
Unlock
. This is
13.40% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$56.9b 28.12%
Unlock
, the lowest is
$46.4b 4.35%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $44.4b 8.69%
2025
$50.4b 13.39%
Unlock
2026
$53.6b 6.44%
Unlock
2027
$56.7b 5.78%
Unlock
2028
$59.3b 4.56%
Unlock
2029
$62.5b 5.37%
Unlock

16 Analysts have issued an Sanofi Sponsored ADR EBITDA forecast 2025. The average Sanofi Sponsored ADR EBITDA estimate is

$15.5b
Unlock
. This is
9.34% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$19.6b 37.75%
Unlock
, the lowest is
$12.4b 12.80%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $14.2b 7.14%
2025
$15.5b 9.35%
Unlock
2026
$16.8b 8.34%
Unlock
2027
$17.5b 3.75%
Unlock
2028
$19.8b 13.62%
Unlock
2029
$20.8b 4.88%
Unlock

EBITDA Margin

2024 31.98% 1.42%
2025
30.84% 3.55%
Unlock
2026
31.39% 1.78%
Unlock
2027
30.78% 1.94%
Unlock
2028
33.45% 8.67%
Unlock
2029
33.30% 0.45%
Unlock

9 Sanofi Sponsored ADR Analysts have issued a net profit forecast 2025. The average Sanofi Sponsored ADR net profit estimate is

$9.2b
Unlock
. This is
53.60% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$10.2b 69.65%
Unlock
, the lowest is
$8.2b 36.81%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $6.0b 3.00%
2025
$9.2b 53.60%
Unlock
2026
$10.3b 11.66%
Unlock
2027
$11.5b 11.29%
Unlock
2028
$13.3b 15.93%
Unlock
2029
$14.9b 12.15%
Unlock

Net Margin

2024 13.54% 5.23%
2025
18.34% 35.44%
Unlock
2026
19.24% 4.91%
Unlock
2027
20.24% 5.20%
Unlock
2028
22.45% 10.92%
Unlock
2029
23.89% 6.41%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share $ 2.40 3.69
3.00% 53.75%
P/E 13.97
EV/Sales 2.72

9 Analysts have issued a Sanofi Sponsored ADR forecast for earnings per share. The average Sanofi Sponsored ADR EPS is

$3.69
Unlock
. This is
53.75% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$4.07 69.58%
Unlock
, the lowest is
$3.28 36.67%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $2.40 3.00%
2025
$3.69 53.75%
Unlock
2026
$4.12 11.65%
Unlock
2027
$4.58 11.17%
Unlock
2028
$5.31 15.94%
Unlock
2029
$5.96 12.24%
Unlock

P/E ratio

Current 21.43 5.88%
2025
13.97 34.81%
Unlock
2026
12.51 10.45%
Unlock
2027
11.24 10.15%
Unlock
2028
9.70 13.70%
Unlock
2029
8.65 10.82%
Unlock

Based on analysts' sales estimates for 2025, the Sanofi Sponsored ADR stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.09 11.15%
2025
2.72 11.91%
Unlock
2026
2.56 6.05%
Unlock
2027
2.42 5.47%
Unlock
2028
2.31 4.36%
Unlock
2029
2.19 5.09%
Unlock

P/S ratio

Current 2.84 11.73%
2025
2.50 11.82%
Unlock
2026
2.35 6.05%
Unlock
2027
2.22 5.47%
Unlock
2028
2.13 4.36%
Unlock
2029
2.02 5.10%
Unlock

Current Sanofi Sponsored ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BERENBERG
Locked
Locked
Locked Apr 07 2025
TD COWEN
Locked
Locked
Locked Apr 06 2025
JEFFERIES
Locked
Locked
Locked Apr 02 2025
LEERINK PARTNERS
Locked
Locked
Locked Mar 30 2025
HSBC
Locked
Locked
Locked Mar 23 2025
BANCO SANTANDER
Locked
Locked
Locked Mar 19 2025
ODDO BHF
Locked
Locked
Locked Mar 13 2025
Analyst Rating Date
Locked
BERENBERG:
Locked
Locked
Apr 07 2025
Locked
TD COWEN:
Locked
Locked
Apr 06 2025
Locked
JEFFERIES:
Locked
Locked
Apr 02 2025
Locked
LEERINK PARTNERS:
Locked
Locked
Mar 30 2025
Locked
HSBC:
Locked
Locked
Mar 23 2025
Locked
BANCO SANTANDER:
Locked
Locked
Mar 19 2025
Locked
ODDO BHF:
Locked
Locked
Mar 13 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today